Stem Cell Research & Therapeutics (4th Annual) (SC)

Venue: Boston

Location: Boston, Massachusetts, United States

Event Date/Time: Apr 17, 2008 End Date/Time: Apr 18, 2008
Registration Date: Apr 16, 2008
Early Registration Date: Mar 17, 2008
Report as Spam


Dear Colleague,

On behalf of GTCbio, we welcome you to our 4th Stem Cell Research and Therapeutics Conference.

In its 4th year, the conference will provide cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and the business of Stem Cells. As alternative sources of human embryonic stem cells emerge, new and exciting federal funding opportunities may arise. The conference will review recent developments in FDA and NIH policies regarding funding for Stem Cell Research. Private funding from the Pharmaceutical Industry will also be addressed. These and other questions will be the highlight of GTCbio`s 2008 Stem Cell Research and Therapeutics conference.

Sessions for the conference include:

Differentiation of Stem Cells
Epigenomics & Reprogramming of Stem Cells
Regenerative Medicine & Therapeutics
Stem Cell Imaging
Cancer Stem Cells
Stem Cell Applications in Drug Discovery
Regulatory Aspects & Funding Opportunities
As in previous conferences, our goal is to create an environment for brainstorming and information exchange in all aspects of Stem Cell research. Your active participation is encouraged and appreciated. Please take the opportunity to ask questions to our speakers and take advantage of the time we have allocated for networking.

This event also provides a unique venue for attendees to network and meet with leading experts in the most comfortable and informal of settings.

We hope you can join your colleagues at this unique forum.
Register by March 17, 2008 and save 10% on registration fee!

Best regards,
2008 Stem Cell Research & Therapeutics Advisory Committee

Special Thanks to our Advisory Board:

Stephen Szilvassy, Amgen
Yanhong Shi, Beckman Res. Inst.
Michael D. West, BioTime
Jay Sharma, Celprogen
Chunhui Xu, Geron
Deepa Deshpande, Johns Hopkins
Mark Wiess, Kansas State Univ.
Yifu Zhou, NIH
Steven W. Kumpf, Pfizer Christophe Labie, Sanofi-Aventis
David T. Harris, University of Arizona
David V. Schaffer, UCB
Asrar Malik, University of Illinois
Joseph Woo, Univ. of Pennsylvania
Eftichia Kontopoulos, Univ. of So. FL.
Joan E. Nichols, University of Texas